THE ARISING · Longevity & Healthspan
Plant Protein Linked to Lower Sarcopenic Obesity Risk Across Three Countries
Plant protein intake was associated with lower sarcopenic obesity risk in three national cohorts. The observational analysis cannot show that changing protein source prevents the combination of muscle loss and central obesity.
The work is an observational study that followed 15,175 middle-aged and older adults in three national ageing cohorts: CHARLS (6,395 people, 2011–2015), ELSA (4,880, 2012–2018) and HRS (3,900, 2010–2018). Authors Zhu, Yao and Hu tracked who developed sarcopenic obesity, a condition in which muscle loss and central obesity occur together.
The researchers defined it as low handgrip strength plus low lean mass in the arms and legs, alongside central obesity. Among participants free of the condition at the start, 633 of 6,275 (10.1%) in CHARLS, 344 of 4,822 (7.1%) in ELSA and 269 of 3,836 (7.0%) in HRS developed it.
Plant protein stood out. Each higher step in plant protein intake (one standard deviation) was linked to a lower risk of developing the condition, with a pooled hazard ratio of 0.86 (95% confidence interval 0.81–0.92). The result was similar in each cohort: 0.90 in CHARLS, 0.82 in ELSA and 0.84 in HRS.
Total protein told a less steady story. It was linked to lower risk in CHARLS (0.91) and ELSA (0.79) but not in HRS (0.92, with an interval that crossed 1.0). According to the authors, the total protein link was attributable mainly to plant protein. Animal protein showed no independent association.
The plant protein link was confined to people with central obesity. In that group the stratified hazard ratios ran from 0.79 to 0.84, compared with 0.90 to 1.06 in people without it. The pooled interaction hazard ratio was 0.75 (0.65–0.86).
The team also modelled swaps. Replacing animal protein with plant protein, at 5% of daily energy, was associated with lower risk, with a pooled hazard ratio of 0.66 (0.54– 0.81).
The authors tested whether biological ageing could help explain the pattern. They used PhenoAge, a measure of ageing built from blood markers. Each higher step in plant protein density was associated with a PhenoAge acceleration value 0.81 to 0.88 years lower. Faster PhenoAge was in turn linked to more sarcopenic obesity, with a hazard ratio of 1.15 to 1.24 per standard deviation. Point estimates suggested 12–16% of the plant protein association passed through this route, though the confidence intervals were wide. These are statistical biomarker associations, not proof that a diet change slowed ageing by that amount.
The link also appeared to run in both directions. People who already had sarcopenic obesity at the start went on to eat 2.9 to 4.2 grams less protein per day, so some of the pattern may reflect illness changing diet rather than diet shaping illness.
The authors conclude that plant protein density, rather than total or animal protein, showed the most consistent inverse association with incident sarcopenic obesity, particularly in people with central obesity. The next question is whether trials that directly swap animal for plant protein in older adults can confirm the pattern.